Premier Biomedical(OTC) BIEI

Current Price$0.00

Market Cap$1.30M

Since IPO (2012)-100%

5 Year-70%

1 Year+67%

1 Month-9%

Premier Biomedical last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-07-24

Premier Biomedical stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-16.67%	USD 0.00	2026-07-17
1 month	-9.09%	USD 0.00	2026-06-24
3 month	-23.08%	USD 0.00	2026-04-24
Year to date	+122.22%	USD 0.00	2025-12-31
1 year	+66.67%	USD 0.00	2025-07-24
3 year	+33.33%	USD 0.00	2023-07-25
5 year	-69.6%	USD 0.00	2021-07-23
Since inception	-100%	USD 287.50	2012-08-08

Premier Biomedical Financials at a Glance

Market Cap

$1.30M

Revenue (TTM)

$0.00

Net Income (TTM)

-$88.48K

EPS (TTM)

-$0.00

P/E Ratio

-10.00

Dividend

$0.00

Beta (Volatility)

0.24 (Low)

Dividend

$0.00

Beta (Volatility)

0.24 (Low)

Price

$0.00

Volume

18,721,989

Open

$0.00

Price

$0.00

Volume

18,721,989

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

0.24 (Low)

Price

$0.00

Volume

18,721,989

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

BIEI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Premier Biomedical

Premier Biomedical, Inc. is a research-based company focused on discovering and developing innovative medical products for the treatment of PTSD, cancer, and various other diseases. The company offers a range of pain management products and is actively developing new therapies utilizing hemp oil extracts.

Products and Services

Hemp oil-based pain relief patches and topical applicators
Sequential-dialysis technique for treating life-threatening conditions
Feldetrex drug candidate for multiple sclerosis and traumatic brain injuries

Growth Outlook

Expansion into new therapeutic areas, including Alzheimer's and ALS
Increasing demand for natural pain management solutions
Potential partnerships to enhance product distribution and development

Financial Highlights

Recent quarterly net income of -$13,425, showing reduced operating expenses
Trailing twelve months (TTM) revenue remains at $0, indicating growth potential
Market capitalization of approximately $1.2 million, reflecting investor interest

Premier Biomedical, Inc. operates in the healthcare sector, specifically within the medical and pharmaceutical industry. The company is headquartered in Jackson Center, Pennsylvania, and has been in operation since 2010. With a focus on innovative treatments, Premier Biomedical aims to address significant health challenges through its diverse product offerings. The company's commitment to research and development positions it well for future growth, particularly in the expanding market for natural and effective medical solutions.

AI Generated • Jul 20, 2026

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Ivan Mendez

Website

www.premierbiomedical.com

Headquarters

Knoxville, PA 16133, US

BIEI Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

3.41%

Return on Capital

N/A

Return on Assets

-2756.48%

Earnings Yield

-10.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.30M

Shares Outstanding

1.30B

Volume

18.72M

Avg. Volume

31.04M

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$88.48K

EBITDA

-$88.48K

Operating Cash Flow

-$190.49K

Capital Expenditure

$0.00

Free Cash Flow

-$190.49K

Cash & ST Invst.

$76.00

Total Debt

$750.60K

Premier Biomedical Performance Analysis

Premier Biomedical annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 0	N/A
2023	2023-12-31	USD 0	N/A
2024	2024-12-31	USD 0	N/A
2025	2025-12-31	USD 0	N/A

Premier Biomedical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	N/A
Q3	2025-09-30	N/A
Q4	2025-12-31	N/A
Q1	2026-03-31	N/A

Premier Biomedical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD 0.00	N/A
2023	2023-12-31	USD -0.00	N/A
2024	2024-12-31	USD -0.00	-50.0%
2025	2025-12-31	USD -0.00	0.0%

Premier Biomedical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	N/A
Q3	2025-09-30	N/A
Q4	2025-12-31	N/A
Q1	2026-03-31	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.30M

N/A

Market Cap/Employee

$325.00K

N/A

Employees

N/A

Net Income

-$13.43K

-8.4%

EBITDA

-$13.43K

-8.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$76.00

-81.6%

Total Debt

$750.60K

+6.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$750.60K

+6.7%

Return on Assets

-27.56%

N/A

Return on Invested Capital

3.43%

N/A

Free Cash Flow

-$19.50K

-764.6%

Operating Cash Flow

-$19.50K

-764.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ITNSItonis, Inc.

ITNSItonis, Inc.$0.00+0.00%

MSMYMC Endeavors, Inc.

MSMYMC Endeavors, Inc.$0.00+0.00%

DYNTDynatronics Corporation

DYNTDynatronics Corporation$0.04+0.00%

VRTHFIndigenous Bloom Hemp Corp.

VRTHFIndigenous Bloom Hemp Corp.$0.00+0.00%

STMHStem Holdings, Inc.

STMHStem Holdings, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.42-0.04%

ONDSOndas

ONDSOndas$7.80-0.02%

SOFISoFi Technologies

SOFISoFi Technologies$16.46-0.01%

TAT&T

TAT&T$24.13+0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.48+0.07%

CLFCleveland-Cliffs

CLFCleveland-Cliffs$11.93+0.09%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$64.00-0.03%

Questions About BIEI

What is the current price of Premier Biomedical?

Premier Biomedical is trading at $0.00 per share.

What is the 52-week range for Premier Biomedical?

Over the past 52 weeks, Premier Biomedical has traded between $0.00 and $0.00.

How much debt does Premier Biomedical have?

As of the most recent reporting period, Premier Biomedical reported total debt of $750.60K.

How much cash does Premier Biomedical have on hand?

Premier Biomedical reported $76.00 in cash and cash equivalents in its most recent financial results.

What is Premier Biomedical’s dividend yield?

Premier Biomedical does not currently have a dividend yield.

Premier Biomedical(OTC) BIEI

Premier Biomedical Financials at a Glance

BIEI News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Premier Biomedical

BIEI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Premier Biomedical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BIEI

What is the current price of Premier Biomedical?

What is the 52-week range for Premier Biomedical?

How much debt does Premier Biomedical have?

How much cash does Premier Biomedical have on hand?

What is Premier Biomedical’s dividend yield?

Premium Investing Services